Expert Insight

Weight management drugs have an image issue

While many health leaders are excited by the promise of new weight management drugs, including GLP-1s like Wegovy, others see new drugs with old problems. What can we learn from these perceptions? By looking at opinions about three existing medications, we explore the challenges and opportunities that lie ahead for weight management drugs.
AdobeStock_642751321 (Expert insight weight management drug comparators)


SPONSORED BY

INTENDED AUDIENCE
  • All healthcare organizations

AFTER YOU READ THIS
  • You will better understand the validity of payer and provider perspectives on GLP-1s for weight loss.

  • You will recognize the similarities between the perceptions of GLP-1s and other drugs.

Don't miss out on the latest Advisory Board insights

Create your free account to access 1 resource, including the latest research and webinars.

Want access without creating an account?

   

You have 1 free members-only resource remaining this month.

1 free members-only resources remaining

1 free members-only resources remaining

You've reached your limit of free insights

Become a member to access all of Advisory Board's resources, events, and experts

Never miss out on the latest innovative health care content tailored to you.

Benefits include:

Unlimited access to research and resources
Member-only access to events and trainings
Expert-led consultation and facilitation
The latest content delivered to your inbox

You've reached your limit of free insights

Become a member to access all of Advisory Board's resources, events, and experts

Never miss out on the latest innovative health care content tailored to you.

Benefits include:

Unlimited access to research and resources
Member-only access to events and trainings
Expert-led consultation and facilitation
The latest content delivered to your inbox
AB
Thank you! Your updates have been made successfully.
Oh no! There was a problem with your request.
Error in form submission. Please try again.